Skip to main content

Advertisement

SpringerLink
Log in

Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Human mast cells are categorized into mast cells positive only for tryptase (MCT) and mast cells positive for both tryptase and chymase (MCTC). The structural appearance of tryptase-, and chymase-positive mast cells in metastatic liver disease and the variations in MCT and MCTC numbers in accordance with the origin of the primary tumors have been described in the present study. Liver mast cells are analyzed immunocytochemically using tryptase and chymase and by quantitative morphometry in 30 patients with colorectal (n=15), gastric (n=8), and pancreatic (n=7) cancers and in 5 control livers. The numbers of MCT and MCTC are increased in the extratumoral liver tissue (mainly portal tracts) as compared to controls. The numbers of MCT and MCTC in and around metastases with moderate or high grade of differentiation are statistically significantly higher, as compared to those with low grades of differentiation. The numbers of MCTC are greater than that of MCT in the extratumoral liver tissue and in metastases themselves. Ultrastructurally, mast cells immunostained with tryptase and chymase have three types of granules: electron dense granules with darkly precipitated reaction product, electron lucent granules without reaction product and electron lucent granules with sparse reaction product (altered granules). Both types of mast cells have small and large in size granules, resembling the MCTC phenotype described earlier. Tryptase-positive mast cells have granules with discrete scrolls and particulate and beaded pattern. Chymase-positive mast cells have granules with finely granular or particulate material. Substance P (SP)- and vasointestinal polypeptide (VIP)-positive mast cells are not observed in livers with metastases. The present study suggests that liver mast cells are mainly from the MCTC type, and are accumulated in peritumoral and metastatic areas. They may play a role in the formation of tumor stroma, or in tumor immunology in liver metastases from various primary gastrointestinal cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Norrby K, Wooly D. The role of mast cells in mitogenesis and angiogenesis in normal tissue and tumor tissue. Adv Biosci 1993; 89: 71–116.

    CAS  Google Scholar 

  2. Nielsen HJ, Hansen U, Christensen IJ et al. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999; 189: 487–95.

    Article  PubMed  CAS  Google Scholar 

  3. Benitez-Bribiesca L, Wong A, Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 2001; 49: 1061–2.

    PubMed  CAS  Google Scholar 

  4. Rouss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88: 493–9.

    Article  Google Scholar 

  5. Elpek GO, Gelen T, Aksoy NH et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 2001; 54: 940–4.

    PubMed  CAS  Google Scholar 

  6. Lachter J, Stein M, Lichting C et al.Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum 1995; 38: 290–3.

    Article  PubMed  CAS  Google Scholar 

  7. Bowrey PF, King J, Magarey C et al. Histamine, mast cells and tumour cell proliferation in breast cancer: Does preoperative cimetidine administration have an effect? Br J Cancer 2000; 82: 167–70.

    Article  PubMed  CAS  Google Scholar 

  8. Graham R, Graham J. Mast cells and cancer of the cervix. Surg Gynecol Obstet 1966; 123: 2–9.

    Google Scholar 

  9. Pasternak A, Jans P. Mastocytes in the process of cancerogenesis. II. Precancerous conditions and carcinomas of the uterine cervix. Cesk Patol 1986; 22: 214–6.

    Google Scholar 

  10. Beil WJ, Pammer J. In situ detection of the mast cell proteases chymase and tryptase in human lung tissue using light and electron microscopy. Histochem Cell Biol 2001; 116: 483–93.

    Article  PubMed  CAS  Google Scholar 

  11. Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of human T and TCmast cells identified by immunoelectron microscopy. Lab Invest 1988; 58: 682–91.

    PubMed  CAS  Google Scholar 

  12. Theodorou V, Fioramonti J, Bueno L. Integrative neuroimmunology of the digestive tract. Vet Res 1996; 27: 427–42.

    PubMed  CAS  Google Scholar 

  13. Cutz E, Chan W, Track NS et al. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 1978; 275: 661–2.

    Article  PubMed  CAS  Google Scholar 

  14. Toyoda M, Makino T, Kagaoura M et al. Immunolocalization of substance P in human skin mast cells. Arch Dermatol Res 2000; 292: 418–21.

    Article  PubMed  CAS  Google Scholar 

  15. Stoyanova II, Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem 2002; 104: 185–92.

    Article  PubMed  CAS  Google Scholar 

  16. Gulubova M, Vodenicharov A. Structural examination of tryptase-, and VIP-positive mast cells in the common bile duct of patients with lithiasis. Acta Histochem 2001; 103: 437–52.

    Article  PubMed  CAS  Google Scholar 

  17. Humphrey C, Pitmann G. A simple methylene blue-azure 2 basic fuchsin stain for epoxy-embedded tissue sections. Stain Technol 1974; 49: 9–14.

    PubMed  CAS  Google Scholar 

  18. Syrjänen K, Nuutinen J, Kärjä J. Tumor differentiation and tumor-host interactions as prognostic determinants in squamous cell carcinoma of the lip. Acta Otolaryngol (Stockh) 1986; 101: 152–60.

    Google Scholar 

  19. Haapasalo H, Personen E. Volume corrected mitotic index (M/VINDEX) the standard of mitotic activity in neoplasms. Path Res Pract 1989; 185: 551–4.

    PubMed  CAS  Google Scholar 

  20. Lipponen PK, Eskelinen Y, Collan S et al. Volume-corrected mitotic index in human pancreatic cancer. Relation to histologic grade, clinical stage, and prognosis. Scand J Gastroenterol 1990; 25: 548–54.

    PubMed  CAS  Google Scholar 

  21. Farell DJ, Hines JE, Walls AF et al. Intrahepatic mast cells in chronic liver diseases. Hepatology 1995; 22: 1175–81.

    Article  Google Scholar 

  22. Armbrust T, Batusic D, Ringe B et al. Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol 1997; 26: 1042–54.

    Article  PubMed  CAS  Google Scholar 

  23. Akiyoshi H, Terada T. Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 1998; 29: 112–9.

    Article  PubMed  CAS  Google Scholar 

  24. Yamashiro M, Kouda W, Kono N et al. Distribution of intrahepatic mast cells in various hepatobiliary disorders. Virchows Arch 1998; 433: 471–9.

    Article  PubMed  CAS  Google Scholar 

  25. Tsuneyama K, Kono N, Yamashiro M et al. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis. J Pathol 1999; 189: 609–14.

    Article  PubMed  CAS  Google Scholar 

  26. Cameron RG, Blendis LM, Neuman MG. Accumulation of macrophages in primary sclerosing cholangitis. Clin Biochem 2001; 34: 195–201.

    Article  PubMed  CAS  Google Scholar 

  27. Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 2000; 33: 961–6.

    Article  PubMed  CAS  Google Scholar 

  28. Bamba N, Nakajima S, Andoh A et al. Stem cell factor expressed in human gastric mucosa in relation to mast cell increase in Helicobacter pylori-infected gastritis. Dig Dis Sci 2002; 47: 274–82.

    Article  PubMed  CAS  Google Scholar 

  29. Gulubova MV. Sinusoidal pit cells' morphology in patients with malignant gastrointestinal tumors non-metastasising in the liver. Savr Med (Bul) 1997; 48: 28–32.

    Google Scholar 

  30. Gulubova MV. Ito cell morphology, ?-smooth actin and collagen type IV expression in the liver of patients with gastric and colorectal tumors. Histochem J 2000; 32: 151–64.

    Article  PubMed  CAS  Google Scholar 

  31. Ghiara P, Boraschi D, Villa L et al. In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology 1985; 55: 317–24.

    PubMed  CAS  Google Scholar 

  32. Van Noorden CJF, Jonges TGN, VanMarle J et al. Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B. Clin Exp Metastasis 1998; 16: 159–67.

    Article  PubMed  CAS  Google Scholar 

  33. Terada T, Makimoto K, Terayama N et al. Alpha-smooth muscle actin positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 1996; 24: 706–12.

    Article  PubMed  CAS  Google Scholar 

  34. Nishida M, Uchikawa R, Tegoshi T et al. Migration of neutrophils is dependent on mast cells in nonspecific pleurisy in rats. APMIS 1999; 107: 929–36.

    Article  PubMed  CAS  Google Scholar 

  35. Tani K, Ogushi F, Kido H et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leuk Biol 2000; 67: 585–9.

    CAS  Google Scholar 

  36. Artuc M, Steckelings M, Henz BM. Mast cell-fibroblast interactions: Human mast cells as a source and inducers of fibroblast and epithelial growth factors. J Invest Dermatol 2002; 118: 391–5.

    Article  PubMed  CAS  Google Scholar 

  37. Jolly S, Thomas C, Genicot B et al. Effect of intravenous plateletactivating factor on bovine pulmonary mast cells. J Comp Pathol 2001; 125: 81–9.

    Article  PubMed  CAS  Google Scholar 

  38. Beil WJ, Pammer J. In situ detection of the mast cell proteases chymase and tryptase in human lung tissue using light and electron microscopy. Histochem Cell Biol 2001; 116: 483–93.

    Article  PubMed  CAS  Google Scholar 

  39. Dvorak AM, Costa JJ, Morgan ES et al. Diamine oxidase-gold ultrastructural localization of histamine in human skin biopsies containing mast cells stimulated to degranulate in vivo by exposure to recombinant human stem cell factor. Blood 1997; 90: 2893–900.

    PubMed  CAS  Google Scholar 

  40. Theodorou V, Fioramonti J, Bueno L. Integrative neuroimmunology of the digestive tract. Vet Res 1996; 27: 427–42.

    PubMed  CAS  Google Scholar 

  41. Ashraf S, Loizidou M, Crowe R et al. Blood vessels in liver metastases from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells. Clin Exp Metastasis 1997; 15: 484–98.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Medical Faculty, Thracian University, Stara Zagora, Bulgaria

    Maya Vladova Gulubova

Authors
  1. Maya Vladova Gulubova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maya Vladova Gulubova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gulubova, M.V. Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers. Clin Exp Metastasis 20, 611–620 (2003). https://doi.org/10.1023/A:1027310827655

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1027310827655

Search

Navigation